Furthermore, patients with both CagA expression and nuclear localization of NFATc1 in tumor cells responded to HPE more rapidly than those with either CagA or NFATc1 expression alone, or with no expression of CagA or NFATc1. The gene discussed is NFATC1; the disease is neoplasm.